Title: A phase II randomized study of cisplatin-pemetrexed plus either enzastaurin or placebo in chemonaive patients with advanced non-small cell lung cancer
Authors: Vansteenkiste, Johan ×
Ramlau, Rodryg
von Pawel, Joachim
San Antonio, Belen
Eschbach, Corinna
Szczesna, Aleksandra
Kennedy, Liam
Visseren-Grul, Carla
Chouaki, Nadia
Reck, Martin #
Issue Date: 2012
Publisher: S. Karger
Series Title: Oncology: International Journal of Cancer Research and Treatment vol:82 issue:1 pages:25-9
Abstract: Enzastaurin is a serine/threonine kinase inhibitor that targets protein kinase C and AKT pathways. Enzastaurin and pemetrexed demonstrated synergy in preclinical studies. This trial was designed to evaluate the safety and efficacy of first-line enzastaurin plus cisplatin-pemetrexed in advanced non-small cell lung cancer (NSCLC).
ISSN: 0030-2414
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Pneumology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science